ARIA Peptide
Intelligence

40 peptides. 9 categories. 15 clinical tools. One platform.

0
Peptides
0
Categories
0
Clinical Tools
Scroll to explore

The Library

40 peptides, each meticulously profiled with evidence grading, mechanism of action, dosing protocols, regulatory status, and key literature citations — all at your fingertips.

AOD-9604

MetabolicEmerging

AOD-9604 + GHRP Stack

MetabolicEmerging

Acetyl Tetrapeptide-3

Skin / AestheticExp.

Adipotide

MetabolicExp.

Ala-GHK Copper Peptide

Anti-AgingClinical

Amycretin

MetabolicExp.

Argireline

Skin / AestheticClinical

BPC-157

RegenerationEmerging
65Peptides
Metabolic (9)Skin / Aesthetic (7)Anti-Aging (6)Regeneration (6)Hormonal (12)Sexual Wellness (3)Neuroprotection (8)Muscular (7)Immune (7)

AI Protocol Designer

Tell ARIA about your patient — their history, goals, and constraints — and receive a curated, evidence-backed protocol with precise dosing, timing, and monitoring plans.

👤
Patient ProfileStep 1

Age, weight, conditions

📋
Medical HistoryStep 2

Contraindications, medications

💉
Procedure StackStep 3

Injectable, topical, nasal

🎯
Goals & OutcomesStep 4

Weight loss, recovery, longevity

Generated Protocol

DRAFT
CJC-1295 / Ipamorelin
100 mcg / 100 mcgSubQ, nightly × 12 weeks
BPC-157
250 mcg BIDSubQ, morning & evening × 8 weeks
Tesamorelin
2 mg QDSubQ, bedtime × 16 weeks
⚕️ Review recommended before prescribing

Synergy Map

See how peptides work together — and where caution is needed. ARIA maps synergistic pairings and flags interactions so you can design safer, more effective protocols.

CJC-1295IpamorelinBPC-157TesamorelinEpitalonThymosin α1SelankTB-500PT-141GHK-CuSynergyCaution

Synergistic Pairings

CJC-1295 + Ipamorelin amplifies GH pulsatility. BPC-157 + TB-500 accelerates tissue repair through complementary pathways.

Caution Zones

Concurrent GH secretagogues may amplify IGF-1 elevation. Immunomodulators near neuroactives require careful timing.

Evidence-Linked

Every connection is backed by published research. Tap any edge to see the supporting citations and clinical notes.

Lab Monitoring

Safety is non-negotiable. ARIA tracks your patient's key biomarkers across the protocol timeline, flagging values that drift outside normal ranges with actionable alerts.

IGF-1
245100-300 ng/mL
normal
Glucose (fasting)
10870-100 mg/dL
elevated
HbA1c
5.9%< 5.7%
elevated
CBC (WBC)
7.24.5-11.0 K/µL
normal
Liver (ALT)
427-56 U/L
normal
Creatinine
1.40.7-1.3 mg/dL
flagged

Lab Order Timeline

Week 0✓ Done
Week 2✓ Done
Week 4✓ Done
Week 6✓ Done
Week 8Next
Week 12

Patient Management

From the first consult to long-term outcomes — ARIA tracks every touchpoint, ensuring nothing falls through the cracks and every patient gets consistent, data-driven care.

Patient Journey

👤
Initial Consult

Goals assessment, history review

📋
Screening Report

Contraindications cleared

🧬
Protocol Assigned

CJC/Ipa + BPC-157 stack

💉
Week 4 Follow-upActive

Adherence check, adjust dosing

🔬
Week 8 Labs

IGF-1, metabolic panel

📊
Outcome Review

12-week comprehensive assessment

Outcome Trends

Patient: J.D. · Protocol: Weight Management

82.4
W0
81.8
W2
80.9
W4
79.5
W6
78.2
W8
77.1
W10
Starting: 82.4 kg-5.3 kg total
92%
Protocol Adherence
33 of 36 doses administered

Patient Handouts

Branded, personalized education materials generated in seconds. Every handout includes dosing schedules, storage instructions, expected effects, and safety information — ready to print or share digitally.

ARIA
Patient Protocol Handout
Patient: J. Doe
Date: Jan 15, 2026

CJC-1295 / Ipamorelin

Growth Hormone Secretagogue Stack

Dosing Schedule
Dose: 100 mcg each
Route: Subcutaneous
Frequency: Once daily
Timing: Bedtime
Duration: 12 weeks
Cycle: 5 on / 2 off
Common Effects
  • • Injection site redness
  • • Mild headache
  • • Flushing
  • • Water retention
Storage
  • • Refrigerate 2-8°C
  • • Protect from light
  • • Use within 28 days
  • • Room temp prep only
ARIA Peptide Intelligence PlatformPage 1 of 2

Practice Analytics

Your practice, quantified. Track patient volume, protocol distribution, visit frequency, and outcome metrics — all in a single dashboard that helps you make data-driven decisions.

👥
0
Active Patients+12%
🧬
0
Protocols Running+8%
📅
0
Avg. Visits/Patient+3%
📊
0%
Outcome Score+5%

Monthly Patient Growth

42
Aug
58
Sep
71
Oct
89
Nov
112
Dec
134
Jan

The Complete Workflow

One platform, every step. From peptide discovery to patient outcomes, ARIA connects the entire clinical workflow into a seamless, intelligent experience.

📚
Library
Browse 40 peptides
🧪
Design
AI protocol builder
⚖️
Compare
Side-by-side analysis
🔬
Labs
Monitor biomarkers
📅
Schedule
Follow-up timeline
📄
Handouts
Patient education
📊
Analytics
Practice insights

Ready to Transform Your Practice?

Join the clinicians already using ARIA to deliver evidence-backed peptide therapy with confidence, efficiency, and better patient outcomes.

Evidence-graded · HIPAA-aligned · Continuously updated · Built for clinicians, by clinicians